TrialBone marrow transplantation2017
When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?
C Solano et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it